$MO The FDA said its approval follows a "rigorous science-based review through the premarket tobacco product application pathway." The agency determined "authorizing these products for the U.S. market is appropriate for the protection of the public health because, among several key considerations, the products produce fewer or lower levels of some toxins than combustible cigarettes."